Table 2.
n (%)/Mean ± Standard Deviation | African (n = 1) | Americas (n = 21) | EMR (n = 1) | European (n = 54) | SEAR (n = 1) | Western Pacific (n = 31) | Global (n = 109; 10.1% of Total) |
---|---|---|---|---|---|---|---|
Year the 1st program opened | - | 1982 | 2012 | 1979 | - | 1968 | 1968 |
% pts served | - | 28.5 ± 27.0 x̃ = 20.0 Q25–Q75 = 5.0–42.5 |
10.0 ± 0.0 x̃ = 10.0 Q25–Q75 = 10.0–10.0 |
43.7 ± 30.6 x̃ = 40.0 Q25–Q75 = 20.0–69.0 |
50.0 ± 0.0 x̃ = 50.0 Q25–Q75 = 50.0–50.0 |
38.5 ± 38.6 x̃ = 20.0 Q25–Q75 = 5.0–83.8 |
38.1 ± 32.3 x̃ = 27.5 Q–25–75 = 10.0–61.3 |
Where provided | |||||||
Public centre | - | 15 (71.4%) | 1 (100.0%) | 25 (46.3%) | 0 (0.0%) | 21 (67.7%) | 62 (56.9%) |
Private centre | - | 2 (9.5%) | 0 (0.0%) | 17 (31.5%) | 0 (0.0%) | 4 (12.9%) | 23 (21.1%) |
Semi-private centre | - | 0 (0.0%) | 0 (0.0%) | 6 (11.1%) | 1 (100.0%) | 1 (3.2%) | 8 (7.3%) |
Dose | |||||||
Sessions pts prescribed/month | - | 9.1 ± 4.5 x̃ = 9.0 Q25–Q75 = 4.0–12.0 |
- | 9.0 ± 9.1 x̃ = 8.0 Q25–Q75 = 4.0–10.0 |
2.0 ± 0.0 x̃ = 2.0 Q25–Q75 = 2.0–2.0 |
6.6 ± 5.3 x̃ = 5.0 Q25–Q75 = 2.0–11.0 |
8.3 ± 7.3 x̃ = 8.0 Q25–Q75 = 4.0–12.0 |
Duration (months) | - | 5.5 ± 1.5 x̃ = 4.0 Q25–Q75 = 3.0–6.3 |
3.0 ± 0.0 x̃ = 3.0 Q25–Q75 = 3.0–3.0 |
2.9 ± 3.4 x̃ = 2.0 Q25–Q75 = 2.0–3.0 |
7.5 ± 0.0 x̃ = 7.5 Q25–Q75 = 7.5–7.5 |
3.4 ± 3.6 x̃ = 2.0 Q25–Q75 = 1.5–3.0 |
3.7 ± 3.7 x̃ = 2.5 Q25–Q75 = 1.0–3.0 |
Provider most responsible to supervise exercise sessions | |||||||
Exercise physiologist or physiotherapist | - | 10 (47.6%) | 1 (100.0%) | 20 (37.0%) | 0 (0.0%) | 9 (29.0%) | 40 (36.7%) |
Nurse | - | 3 (14.3%) | 0 (0.0%) | 16 (29.6%) | 1 (100.0%) | 8 (25.8%) | 28 (25.7%) |
Physician | - | 2 (9.5%) | 0 (0.0%) | 6 (11.1%) | 0 (0.0%) | 5 (16.1%) | 13 (11.9%) |
Basis for Offering | |||||||
Patient choice | - | 15 (71.4%) | 0 (0.0%) | 38 (70.4%) | 1 (100.0%) | 19 (61.3%) | 73 (67.0%) |
Risk stratification | - | 13 (61.9%) | 0 (0.0%) | 26 (48.1%) | 1 (100.0%) | 11 (35.5%) | 51 (46.8%) |
Distance to main CR centre | - | 16 (76.2%) | 1 (100.0%) | 18 (33.3%) | 1 (100.0%) | 13 (41.9%) | 49 (45.0%) |
Patient indication | - | 8 (38.1%) | 0 (0.0%) | 24 (44.4%) | 1 (100.0%) | 13 (41.9%) | 46 (42.2%) |
Transportation barriers | - | 14 (66.7%) | 1 (100.0%) | 17 (31.5%) | 0 (0.0%) | 11 (35.5%) | 43 (39.4%) |
Time or work constraints | - | 15 (71.4%) | 1 (100.0%) | 13 (24.1%) | 0 (0.0%) | 11 (35.5%) | 40 (36.7%) |
Cost | - | 3 (14.3%) | 0 (0.0%) | 6 (11.1%) | 0 (0.0%) | 2 (6.5%) | 11 (10.1%) |
Not having a main centre in a clinical setting | - | 1 (4.8%) | 0 (0.0%) | 5 (9.6%) | 0 (0.0%) | 2 (6.5%) | 8 (7.3%) |
Capacity Indicators | |||||||
Number sessions offered per week | - | 5.7 ± 8.1 x̃ = 3.0 Q25–Q75 = 1.8–6.3 |
- | 4.7 ± 6.1 x̃ = 3.0 Q25–Q75 = 2.0–5.0 |
2.0 ± 0.0 x̃ = 2.0 Q25–Q75 = 2.0–0.0 |
3.8 ± 3.4 x̃ = 2.0 Q25–Q75 = 1.0–6.0 |
4.6 ± 6.0 x̃ = 3.0 Q25–Q75 = 2.0–6.0 |
Pts per session | - | 16.9 ± 19.5 x̃ = 10.0 Q25–Q75 = 7.5–15.0 |
- | 15.3 ± 14.8 x̃ = 12.0 Q25–Q75 = 9.3–15.0 |
10.0 ± 0.0 x̃ = 10.0 Q25–Q75 = 10.0–10.0 |
11.4 ± 8.1 x̃ = 10.0 Q25–Q75 = 8.0–15.0 |
14.6 ± 14.5 x̃ = 10.0 Q25–Q75 = 9.0–15.0 |
Exercise Monitoring | |||||||
Heart rate | - | 10 (47.6%) | 0 (0.0%) | 23 (42.6%) | 0 (0.0%) | 14 (45.2%) | 47 (43.1%) |
Borg perceived exertion [34] | - | 8 (38.1%) | 1 (100.0%) | 23 (42.6%) | 0 (0.0%) | 14 (45.2%) | 46 (42.2%) |
Telemetry | - | 0 (0.0%) | 0 (0.0%) | 5 (9.6%) | 0 (0.0%) | 4 (12.9%) | 9 (8.3%) |
Level of Risk Accepted | |||||||
High | - | 4 (19.0%) | 0 (0.0%) | 22 (40.7%) | 0 (0.0%) | 7 (22.6%) | 33 (30.3%) |
Moderate | - | 13 (61.9%) | 0 (0.0%) | 37 (68.5%) | 1 (100.0%) | 18 (58.1%) | 69 (63.3%) |
Low | - | 17 (81.0%) | 1 (100.0%) | 42 (77.8%) | 1 (100.0%) | 16 (51.6%) | 77 (70.6%) |
Do not risk stratify | - | 2 (9.5%) | 0 (0.0%) | 2 (3.7%) | 0 (0.0%) | 5 (16.1%) | 9 (8.3%) |
x̃ = median; - no response; Abbreviations: pts = patients; Acronyms: SEAR = South-East Asia region; EMR = Eastern Mediterranean region.